Atlas Trials

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

Clinical trial NCT01224067 · COMPLETED

Trial details

NCT number
NCT01224067
Sponsor
Cambridge Health Alliance
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Social Anxiety Disorder
Start date
2006-03-01
Primary completion
2008-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.